Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Formosa Laboratories Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - FORMOSA LABORATORIES, INC (4746-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Apr 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Formosa Laboratories, Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Apr 2015 Wright Reports 55 $75.00

Formosa Lab (4746 TT, NT$63.9, OP): Upcoming API launches to accelerate 2015F earnings growth

Event Formosa Lab held an analyst meeting today. Management’s 2015 outlook is intact for polymer API shipments on the upcomi...

13 Apr 2015 KGI Greater China 7 $69.00

台耀 (4746 TT, NT$63.9, 增加持股): 聚合物原料藥產品出貨在即,15年獲利可望加速攀升

重要訊息 台耀本日召開法說。管理層看好聚合物原料藥進入出貨成長上升循環在即,對於2015年的堅實展望表示信心。 評論及分析 估計2015整年度季營收已築底。1Q15營收季增0.4%但年減13.3%至5.28億元,符合市場共識5.30億元,而...

13 Apr 2015 KGI Greater China 7 $58.00

Formosa Laboratories (4746 TT); Strong Demand for Cholesterol and Phosphate Binders

We forecast Formosa’s FY15 sales at NT$2.7bn, +10% YoY with API sales contributing to sales by NT$2.16bn. +39% YoY. The compa...

08 Mar 2015 MasterLink Securities Corporation 6 $58.00

台耀 (4746):走出UV陰霾,膽固醇磷酸鹽供不應求

元富預估2015年營收27億元,YOY +10%,其中API營收為21.6億元,YOY +39%,成長動能來自膽固醇磷酸鹽與維他命D衍生物,由於台耀低毛利率的UV 出貨持續減少,因此將空出的產能生產中間體,降低API生產成本,2015年UV營收比重從...

02 Mar 2015 MasterLink Securities Corporation 5 $35.00

Formosa Laboratories, Inc. (4746) - Financial Analysis Review

Formosa Laboratories, Inc. (4746) - Financial Analysis Review Summary Formosa Laboratories, Inc. (Formosa) is a pharmac...

12 Feb 2015 GlobalData 29 $125.00

台耀 (4746 TT, NT$68.0, 增加持股): 4Q14營收優於預期

重要訊息 12月營收月增74.1%至2.49億元;4Q14營收相當於凱基預估107.1%,與市場預期相符。 評論及分析 原料藥出貨強勁,12月營收優於預期。4Q14營收雖季減11%且年減31%至5.13億元,仍符合市場共識5.23億元,並較...

07 Jan 2015 KGI Greater China 6 $46.00

Formosa Lab (4746 TT, NT$68.0 OP): 4Q14 sales better than expected

Event December sales rose 74.1% MoM to NT$249mn, achieving 107% of our 4Q14 forecast, and in line with consensus. Impac...

07 Jan 2015 KGI Greater China 6 $58.00